Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants

- Meinel, Thomas R., Wilson, Duncan, Suzuki, Kentaro, Kimura, Kazumi, Macha, Kosmas, Koga, Masatoshi, Wada, Shinichi, Altersberger, Valerian, Salerno, Alexander, Palanikumar, Logesh, Zini, Andrea, Forlivesi, Stefano, Gensicke, Henrik, Garcia-Esperon, Carlos, Wischmann, J, Kristoffersen, ES, Beharry, J, Barber, PA, Hong, JB, Cereda, C, Schlemm, E, Yakushiji, Y, Poli, S, Scheitz, Jan F., Leker, R, Romoli, M, Zedde, M, Curtze, S, Ikenberg, B, Uphaus, T, Giannandrea, D, Portela, PC, Veltkamp, R, Ranta, A, Ringleb, Peter, Arnold, M, Fischer, U, Cha, JK, Wu, TY, Purrucker, JC, Seiffge, DJ, Kägi, G, Engelter, S, Nolte, CH, Kallmünzer, B, Goganau, Ioana, Michel, P, Kleinig, TJ, Fink, J, Rønning, OM, Campbell, B, Nederkoorn, PJ, Thomalla, G, Kunieda, T, Poli, K, Béjot, Y, Kaesmacher, Johannes, Soo, Y, Garcia-Esperon, C, Ntaios, G, Cordonnier, C, Marto, JP, Bigliardi, G, Lun, F, Choi, PMC, Steiner, T, Ustrell, X, Bae, Hee-Joon, Werring, D, Wegener, S, Pezzini, A, Du, H, Martí-Fàbregas, J, Cánovas-Vergé, D, Strbian, D, Padjen, V, Yaghi, S, Stretz, C, Kim, Do Yeon, Kim, JT, Kermer, Pawel

Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial

- Meretoja, Atte, Yassi, Nawaf, Wu, Teddy Y., Churilov, Leonid, Sibolt, Gerli, Jeng, Jiann-Shing, Kleinig, Timothy, Spratt, Neil J., Thijs, Vincent, Wijeratne, Tissa, Cho, Der-Yang, Shah, Darshan, Cloud, Geoffrey C., Phan, Thanh, Bladin, Christopher, Moey, Andrew, Aviv, Richard I., Barras, Christen D., Sharma, Gagan, Hsu, Chung Y., Levi, Christopher, Ma, Henry, Campbell, BCV, Mitchell, P, Yan, B, Parsons, MW, Tiainen, M, Curtze, S, Strbian, D, Tang, SC, Harvey, J, Donnan, GA, Davis, SM